Alkaptonuria (AKU) is a rare autosomal recessive disease, affecting tyrosine metabolism. Patients accumulate homogentisic acid at 2000 times the normal rate, resulting in cartilage degradation and symptoms similar to early-onset osteoarthritis.

Campaign launched to find a cure for rare disease linked to osteoarthritis

Written by Oliver, published 4 months ago.

Liverpool, UK, 18 November 2011 - A campaigning patient group has today launched a five million-pound appeal to fund a ground-breaking clinical trial to test the drug nitisinone as a potential treatment for alkaptonuria (AKU), commonly known as black bone disease.

Although a rare disease, medical researchers at the AKU Society believe an effective treatment for the condition could also open new lines of inquiry into treating the millions of patients in the UK who suffer from osteoarthritis.

“Anything we can do to understand AKU, which is a severe form of arthritis, will undoubtedly help us to understand other forms of arthritis such as osteoarthritis” said Dr Lakshminarayan Ranganath, Medical Director for the AKU Society. “Osteoarthritis is a highly prevalent disease affecting at least eight million people in the UK."(i)

“Normally, clinical trials are designed and developed by pharmaceutical companies as it’s a complicated and expensive business,” said Nick Sireau, AKU Society Chairman, whose two young sons suffer from the rare genetic condition. “No pharmaceutical company as yet has committed to take on the Phase III trial. We hope they will, but if necessary we will take on both the development and the fundraising - and pay for it ourselves.”

The AKU Society will launch the campaign at the opening of its annual conference in Liverpool today, attended by more than 80 medical researchers from around the world. The society believes it could soon lead to the first treatment for AKU, with the potential to improve patients’ quality of life dramatically.

Nick’s hard work could mean his two young sons, diagnosed as babies with AKU, will not have to suffer the debilitating consequences of the disease, which typically leads to severe joint pain, early-onset osteoarthritis, an inability to work and the need for joint replacement surgery in middle age.

Written by Oliver, published 4 months ago.

No comment for «Campaign launched to find a cure for rare disease linked to osteoarthritis»

Expand all ]

No comment yet.

Leave a comment

You must be registered and signed in to leave a comment. Sign in now.

Alkaptonuria (AKU) Recent Activity

  • -

    Allergy
    topic, published 10 days ago

    show transcript

    I suffer since my childhood of different allergic reactions (rhinitis, cutaneous reactions and more recently I had twice a beginning of respiratory oedema without being able to determine exactly its origin ).
    I' m wondering if there are other Aku- patients suffering from allergy?
    I've been ...

  • -

    New abstract on AKU and shoulder prosthesis
    topic, published about 1 month ago

    show transcript

    Ochronotic arthropathy: diagnosis and management:

    http://www.ncbi.nlm.nih.gov/pubmed/22482092?dopt=Abstract

    But what's a rritical review? critical review??

  • -

    Nitisinone
    topic, published about 1 month ago

    show transcript

    Hi,
    Is there the possibility of entering a clinical trial for the drug Nitisinone?
    Thanks.

  • -

    Degenerative Arthritis of the Knee Secondary to Ochronosis
    document, published 5 months ago

    show transcript

    Bulletin of the NYU Hospital for Joint Diseases 2011;69(4):331-4

  • -

    5th International Workshop on AKU
    topic, published 6 months ago

    show transcript

    A selection of presentations from those speakers who have given permission for their slideshows to be published are now available to download on the AKU Society website at:

    http://www.alkaptonuria.info/557296

    Thanks Oliver from the AKU Society

  • -

    LETTRE D’INFORMATION N° 14 (SEPTEMBRE 2011)
    document, published 8 months ago

    show transcript

    Cette lettre est diffusée par courrier postal ou internet aux personnes atteintes d’Alcaptonurie-Ochronose, à leurs familles, aux amis et aux membres de l’ALCAP, aux donateurs, aux médecins et chercheurs, et à toute personne qui s’intéresse à l’Alcaptonurie en France, en Belgique et en Suisse.

  • -

    Update
    topic, published 8 months ago

    show transcript

    After these summer months, with a moody weather season and my health being as variable as the weather, here I am back to you taking a little time to write.

    You certainly know that the AKU Society is organizing the 5th International Workshop on AKU This event will be held at the Medical Institu...

  • -

    Action shot photo competition of EULAR for world arthritis day
    topic, published 8 months ago

    show transcript

    Dear all,
    I just submitted an 'action shot photo’ to enter a competition of
    the European Arthritis Foundation (EULAR) specially designed for the
    world arthritis day. The slogan for this competition is move to
    improve, i.e. how sport can improve mobility or slow down the
    progress of one’s ...

  • -

    AKU Society's Year in Review
    topic, published 10 months ago

    show transcript

    Check it out here:
    http://www.alkaptonuria.info/557292

    While on the website, don't forget to book for the upcoming November meeting in Liverpool:

    http://www.alkaptonuria.info/557296

  • -

    Getting information on AKU...
    topic, published 10 months ago

    show transcript

    The National Institutes of Health have Genetic and Rare Disease (GARD) Information specialists that may be able to help you find information.

    The GARD Information Center does not provide genetic counseling and does not offer diagnostic testing, referrals, medical treatment or advice.

    Ther...